ITMI20020404A1 - Nuova manganese superossido dismutasi umana - Google Patents

Nuova manganese superossido dismutasi umana

Info

Publication number
ITMI20020404A1
ITMI20020404A1 IT2002MI000404A ITMI20020404A ITMI20020404A1 IT MI20020404 A1 ITMI20020404 A1 IT MI20020404A1 IT 2002MI000404 A IT2002MI000404 A IT 2002MI000404A IT MI20020404 A ITMI20020404 A IT MI20020404A IT MI20020404 A1 ITMI20020404 A1 IT MI20020404A1
Authority
IT
Italy
Prior art keywords
human
dismutation
invention refers
manganese superoxide
present
Prior art date
Application number
IT2002MI000404A
Other languages
English (en)
Inventor
Aldo Mancini
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Priority to IT2002MI000404A priority Critical patent/ITMI20020404A1/it
Publication of ITMI20020404A0 publication Critical patent/ITMI20020404A0/it
Priority to AT03706586T priority patent/ATE441703T1/de
Priority to AU2003208771A priority patent/AU2003208771A1/en
Priority to PCT/EP2003/002017 priority patent/WO2003072768A2/en
Priority to PT03706586T priority patent/PT1481056E/pt
Priority to EP03706586A priority patent/EP1481056B1/en
Priority to ES03706586T priority patent/ES2333000T3/es
Priority to DE60329084T priority patent/DE60329084D1/de
Priority to SI200331705T priority patent/SI1481056T1/sl
Priority to DK03706586T priority patent/DK1481056T3/da
Publication of ITMI20020404A1 publication Critical patent/ITMI20020404A1/it
Priority to CY20091101254T priority patent/CY1109524T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2002MI000404A 2002-02-28 2002-02-28 Nuova manganese superossido dismutasi umana ITMI20020404A1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT2002MI000404A ITMI20020404A1 (it) 2002-02-28 2002-02-28 Nuova manganese superossido dismutasi umana
DK03706586T DK1481056T3 (da) 2002-02-28 2003-02-27 Modificeret human mangan-superoxid-dismutase og anvendelser deraf
PT03706586T PT1481056E (pt) 2002-02-28 2003-02-27 Superóxido dismutase de manganésio humano modificado e suas utilizações
AU2003208771A AU2003208771A1 (en) 2002-02-28 2003-02-27 Modified human manganese superoxide dismutase and uses thereof
PCT/EP2003/002017 WO2003072768A2 (en) 2002-02-28 2003-02-27 Modified human manganese superoxide dismutase and uses thereof
AT03706586T ATE441703T1 (de) 2002-02-28 2003-02-27 Modifizierte humane mangan-superoxiddismutase und deren verwendungen
EP03706586A EP1481056B1 (en) 2002-02-28 2003-02-27 Modified human manganese superoxide dismutase and uses therof
ES03706586T ES2333000T3 (es) 2002-02-28 2003-02-27 Manganexo superoxido dismutasa humana modificada y sus usos.
DE60329084T DE60329084D1 (de) 2002-02-28 2003-02-27 Modifizierte humane mangan-superoxiddismutase und deren verwendungen
SI200331705T SI1481056T1 (sl) 2002-02-28 2003-02-27 Modificirana humana mangan superoksid dismutaza in njene uporabe
CY20091101254T CY1109524T1 (el) 2002-02-28 2009-12-01 Τροποποιημενη ανθρωπινη δισμουταση υπεροξειδιου μαγγανιου και οι χρησεις της

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000404A ITMI20020404A1 (it) 2002-02-28 2002-02-28 Nuova manganese superossido dismutasi umana

Publications (2)

Publication Number Publication Date
ITMI20020404A0 ITMI20020404A0 (it) 2002-02-28
ITMI20020404A1 true ITMI20020404A1 (it) 2003-08-28

Family

ID=11449395

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI000404A ITMI20020404A1 (it) 2002-02-28 2002-02-28 Nuova manganese superossido dismutasi umana

Country Status (11)

Country Link
EP (1) EP1481056B1 (it)
AT (1) ATE441703T1 (it)
AU (1) AU2003208771A1 (it)
CY (1) CY1109524T1 (it)
DE (1) DE60329084D1 (it)
DK (1) DK1481056T3 (it)
ES (1) ES2333000T3 (it)
IT (1) ITMI20020404A1 (it)
PT (1) PT1481056E (it)
SI (1) SI1481056T1 (it)
WO (1) WO2003072768A2 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20120026A1 (it) * 2012-02-15 2013-08-16 Aldo Mancini Proteina apo-sod sua preparzione ed uso.
DE102012013482A1 (de) * 2012-07-09 2014-01-09 Bitop Ag Zusammensetzung zur Förderung der Wiederherstellung von verletztem Körpergewebe
ES2763457T3 (es) 2013-11-04 2020-05-28 Aldo Mancini Variantes de superóxido dismutasa de manganeso y usos de las mismas
ITRM20130608A1 (it) * 2013-11-04 2015-05-05 Aldo Mancini Manganese superossido dismutasi ricombinante e usi di essa

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0630404A1 (en) * 1992-03-09 1994-12-28 Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale Protein compound capable of inhibiting tumoral growth

Also Published As

Publication number Publication date
AU2003208771A8 (en) 2003-09-09
PT1481056E (pt) 2009-12-09
WO2003072768A3 (en) 2003-12-24
WO2003072768A2 (en) 2003-09-04
EP1481056B1 (en) 2009-09-02
ATE441703T1 (de) 2009-09-15
WO2003072768A8 (en) 2005-03-17
CY1109524T1 (el) 2014-08-13
ITMI20020404A0 (it) 2002-02-28
EP1481056A2 (en) 2004-12-01
AU2003208771A1 (en) 2003-09-09
DE60329084D1 (de) 2009-10-15
DK1481056T3 (da) 2009-12-21
ES2333000T3 (es) 2010-02-16
SI1481056T1 (sl) 2010-01-29

Similar Documents

Publication Publication Date Title
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
WO2005034940A3 (de) Duale alanyl-aminopeptidase- und dipeptidylpeptidase iv-inhibitoren zur funktionellen beeinflussung unterschiedlicher zellen und zur behandlung immunologischer, entzündlicher, neuronaler und anderer erkrankungen
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
TR200201442T2 (tr) Ağrı hafifletme, kemik kanseri terapisi ve kemik yüzeyinin sağlıklı tutulması için kireçlenmiş hedef dokulara yönelik radyum-223 hazırlanması ve kullanımı.
SE0101387D0 (sv) Novel compounds
MY148246A (en) Bicyclic amides as kinase inhibitors
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
RU2007145489A (ru) Фармацевтические композиции и способы лечения рака и его метастазов
NO20022065L (no) Terapeutisk anvendelse
CA2452151A1 (en) Use of cyclopamine, an inducer of the differentiation and apoptosis of the basal cell carcinoma (bcc) cells, in the treatment of bcc's and other tumors that use the hedgehog/smoothened pathway for proliferation of apoptosis
UA90698C2 (en) Triazole substituted aminobenzophenone compounds
CY1108992T1 (el) Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας
FR2909552B1 (fr) Utilisation cosmetique de l'acide anisique pour favoriser la desquamation
TW200740808A (en) Inhibiteurs de proteines kinases
AU2001266289A1 (en) 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
BR0312294A (pt) Arilcarbonil piperazinas e hteroarilcarbonilpiperazinas e o uso das mesmas para tratamento de doenças benignas e malignas
ATE501719T1 (de) Methoden und zusammensetzungen zur beruhigung von mund- und nasenschleimhäuten
SI1988909T1 (sl) Uporaba polietilenglikola pri topičnih motnjah ali boleznih, povezanih z vnetjem, in zdravljenju ran
ITMI20020404A1 (it) Nuova manganese superossido dismutasi umana
EA200600468A1 (ru) Биполярные транс-каротиноидные соли и их применение
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
EP1595536A4 (en) DRUGS WITH SHIKONIN AS ACTIVE SUBSTANCE
WO2006023623A3 (en) Methods of healing wounds by administering human il-18
DE50210637D1 (de) Verwendung von stimulierten mononuklearen zellen des peripheren blutes zur behandlung von krebserkrankungen
Ingves et al. Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma